Gamma heavy chain disease associated with aggressive B lymphoma in the context of myelodysplastic syndrome von Nivet, C, Deluche, L, Carreiro, M

Volltext

Case report - Hyperthermia and nuclear hypersegmentation of blood cells von Rivière, C, Vimeux, S, Laurens, S, Deluche, L, Juvin, P Y, Sanson, A, Metsu, D

Volltext

Maladie des chaînes lourdes de type gamma associée à un lymphome B diffus à grandes cellules dans un contexte de myélodysplasie von Nivet, C., Deluche, L., Carreiro, M.

Volltext

Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort von Grinda, T., Antoine, A., Jacot, W., Blaye, C., Cottu, P.-H., Diéras, V., Dalenc, F., Gonçalves, A., Debled, M., Patsouris, A., Mouret-Reynier, M.-A., Mailliez, A., Clatot, F., Levy, C., Ferrero, J.-M., Desmoulins, I., Uwer, L., Petit, T., Jouannaud, C., Lacroix-Triki, M., Deluche, E., Robain, M., Courtinard, C., Bachelot, T., Brain, E., Pérol, D., Delaloge, S.

Volltext

A prolactinoma resistant to cabergoline: The important role of surgery von Salle, L., Deluche, E., Géraud, F., Salle, H.

Volltext

Predictors of women’s attendance in a home-based adapted physical activity program during localized breast cancer treatment von Deveautour-Roy, E., Tubiana-Mathieu, N., Léobon, S., Vincent, F., Venat, L., Sombardier, T., Deluche, E., Mandigout, S.

Volltext

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer von Poumeaud, F., Morisseau, M., Cabel, L., Gonçalves, A., Rivier, C., Trédan, O., Volant, E., Frenel, J.-S., Ladoire, S., Jacot, W., Jamelot, M., Foka Tichoue, H., Patsouris, A., Teixeira, L., Bidard, F.-C., Loirat, D., Brunet, M., Levy, C., Bailleux, C., Cabarrou, B., Deleuze, A., Uwer, L., Deluche, E., Grellety, T., Franchet, C., Fiteni, F., Bischoff, H., Vion, R., Pagliuca, M., Verret, B., Bécourt, S., Reverdy, T., de Nonneville, A., Dalenc, F.

Volltext

Compliance to genomic test recommendations to guide adjuvant chemotherapy decision‐making in the case of hormone receptor‐positive, human epidermal growth factor receptor 2‐negativ... von Hequet, D., Hajjaji, N., Charafe‐Jauffret, E., Boucrauta, A., Dalenc, F., Nicolai, V., Lopez, J., Tredan, O., Deluche, E., Fermeaux, V., Tixier, L., Cayre, A., Menet, E., Lerebours, F., Rouzier, R.

Volltext

ACACIAS 1: The physiological and subjective impacts of high fidelity simulation of the breaking of bad news von Deluche, E., Salle, H., Leobon, S., Facchini-Joguet, T., Fourcade, L., Taibi, A.

Volltext

HSD63 New Pathway in Anti-HER2 Treatments’ Administration in Breast Cancer in France: Which Impacts of the Involvement of an Advanced Practice Nurse in Hospital at Home Program? von Pozzar, M., Couillerot, A.L., Gherardi, A., Marchand, L., Le Lay, K., Pallaro, S., Bigas, M., Maillan, G., Deluche, E.

Volltext

483P Prognostic value of androgen receptor expression in patients with advanced triple-negative metastatic breast cancer treated with sacituzumab govitecan: A French multicentre re... von Arnedos, M., Segier, B., Vincent, N., Robert, M., Grinda, T., Grellety, T., Deluche, E., Lehmann-Che, J., Jacot, W., Heymann, M-F., Lusque, A., Brunet, M., Teixeira, L., Guiu, S.

Volltext

343MO Unraveling the mechanisms of action and resistance to trastuzumab deruxtecan (T-DXd): Supplementary biomarker analyses from DAISY trial von Mosele, M.F., Lusque, A., Dieras, V.C., Deluche, E., Ducoulombier, A., Pistilli, B., Bachelot, T., Viret, F., Levy, C., Pradat, Y.C., Signolle, N., Le Bescond, L., Tran, D., Droin, N., Kobayashi, M., Kakewaga, T., Deloger, M., Jimenez, M., Lacroix-Triki, M., André, F.

Volltext

260P Antitumor activity of trastuzumab deruxtecan (T-DXd) in patients with metastatic breast cancer (mBC) and brain metastases (BMs) from DAISY trial von Epaillard, N., Lusque, A., Pistilli, B., André, F., Bachelot, T., Pierga, J-Y., Ducoulombier, A., Jouannaud, C., Viret, F., Salabert, L., Johnson, A.C., Deluche, E., Durando, X., Petit, T., Filleron, T., Mahier Ait Oukhatar, C., Dieras, V.C., Mosele, M.F.

Volltext

2022 : nouvelles pratiques thérapeutiques en oncologie mammaire von Deluche, Elise, Verret, Benjamin

Volltext

819TiP COLIBRI trial (GINECO-CE108b): A multicenter, window study evaluating immune impact and safety of nivolumab in combination with ipilimumab before initial radio-chemotherapy... von Ray-Coquard, I.L., Kaminsky-Forrett, M-C., Joly, F., Montané, L., Bello Roufai, D., Savoye, A.M., Angelergues, A., Hardy-Bessard, A-C., Mouret Reynier, M.A., Deluche, E., Caux, C., Saintigny, P., Péré, H., Treilleux, I., Betrian, S., Lecuru, F.

Volltext

ACACIA 1: The physiological and subjective impacts of high fidelity simulation of the breaking of bad news von Deluche, E, Salle, H, Leobon, S, Facchini-Joguet, T, Fourcade, L, Taibi, A

Volltext

712P Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial von Courcier, J., Dalban, C., Laguerre, B., Ladoire, S., Barthélémy, P., Oudard, S., Joly, F., Gravis Mescam, G., Chevreau, C.M., Geoffrois, L., Deluche, E., Rolland, F., Topart, D., Culine, S., Négrier, S., Mahammedi, H., Tantot, F., Escudier, B., Flippot, R., Albiges, L.

Volltext

CN46 Real-life experience of nurses coordinating device in oral therapy center (DICTO program) von Deluche, E., Darbas, T., Bourcier, K., Montangon, L., Lebrun, V. Ly, Pestre, J., Venat, L., Thuillier, F., Nevado, E., Maillan, G., Bayard, G., Caille, E., Chaput, S., Querrioux, J., Suchaud, C., Zabaleta, S., Leobon, S., Tubiana-Mathieu, N., Lavau-Denes, S.

Volltext

LBA1 Unraveling the mechanism of action and resistance to trastuzumab deruxtecan (T-DXd): Biomarker analyses from patients from DAISY trial von Mosele, M.F., Lusque, A., Dieras, V., Deluche, E., Ducoulombier, A., Pistilli, B., Bachelot, T., Viret, F., Levy, C., Signolle, N., Tran, D., Garberis, I.J., Le-Bescond, L., Dien, A. Tran, Droin, N., Kobayashi, M., Kakegawa, T., Jimenez, M., Lacroix-Triki, M., André, F.

Volltext

Study of sarcopenia according to the criteria of mass, muscle strength and function, at the diagnosis of pancreatic cancer: impact on survival von Salacroup, C., David, C., Fayemendy, P., MISSET, B., Charron, L., Rouchaud, E., Vernier, T., Deluche, E., Jesus, P.

Volltext